Skip to content
2000
Volume 9, Issue 3
  • ISSN: 1574-8855
  • E-ISSN: 2212-3903

Abstract

Oral delivery of vaccines is able to induce systemic as well as mucosal immune responses but is largely inefficient due to intestinal degradation and impermeable barrier property of GIT of administered antigen. Efforts are being made to develop a safe and effective oral vaccination by offering resistant against acidic and enzymatic degradation before reaching to the target site. Several strategies are developed to target antigen to the gut associated lymphoid tissue (GALT) present in the intestine where antigen-specific immune responses are initiated. This review discusses various technologies and targets for antigen delivery to induce protective immunization by oral vaccine.

Loading

Article metrics loading...

/content/journals/cdth/10.2174/1574885509666141202232803
2014-09-01
2025-11-03
Loading full text...

Full text loading...

/content/journals/cdth/10.2174/1574885509666141202232803
Loading

  • Article Type:
    Research Article
Keyword(s): M-cell ligand; mucosal immunity; nanocarriers; oral vaccine
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test